mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines

The advent of the Omicron variant globally has hastened the requirement for a booster vaccination dose to confer continuous protection against symptomatic SARS-CoV2 infection. However, different vaccines are available in different countries, and individuals who had adverse reactions to certain vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Biyan, Huo, Jianxin, Huang, Yuhan, Teo, Shuan Yong, Duan, Kaibo, Li, Yanfeng, Toh, Lim Kai, Lam, Kong Peng, Xu, Shengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315817/
https://www.ncbi.nlm.nih.gov/pubmed/35891221
http://dx.doi.org/10.3390/vaccines10071057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315817/
https://www.ncbi.nlm.nih.gov/pubmed/35891221
http://dx.doi.org/10.3390/vaccines10071057

Ejemplares similares